Molecular Characterization of a Novel Mucopolysaccharidosis (MPS) type VI-causing Mutation – Indirect Proof of Principle on its Pathogenicity

Coutinho, Maria Francisca; Encarnação, M.; Santos, J.I.; Alves, S.

http://hdl.handle.net/10400.18/6289

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Coutinho MF - ARSB +5 mutation.pdf		47.66 KB	Adobe PDF	Download

Send Feedback

Authors

Coutinho, Maria Francisca

Encarnação, M.

Santos, J.I.

Alves, S.

Abstract(s)

Introduction: With its unprecedented throughput, scalability and speed, next-generation sequencing (NGS) is revolutionizing clinical research. Targeted sequencing in particular is now available in many labs. Still, whenever a novel variant is detected, its pathogenicity must be carefully assessed and every now and again, a case pops up to highlight how tricky and delicate this process can be. Here we present a case of a molecular diagnosis of a patient with a clinical suspicion of MPS type VI, where even though the causal mutation was easy to detect by both Sanger and NGS, only through indirect studies could we present proof of principle on its pathogenicity.

Keywords

Lysosomal Storage Diseases Mucopilysaccharidoses ARSB MPS VI Splicing Mutation Doenças Genéticas Genética Humana

URI

http://hdl.handle.net/10400.18/6289

Collections

DGH - Posters/abstracts em congressos internacionais

Full item page